This case demonstrates the unexpected resolution of severe, chronic oral candidiasis in a patient with CMC during treatment of progressive head and neck cancer with pembrolizumab, suggesting a potential, though uncharacterized, beneficial effect of PD-1 blockade in STAT1 GOF CMC. The gene discussed is STAT1; the disease is Chronic oral candidiasis.